Last reviewed · How we verify

NCT03843762

Harnessing Sleep/Circadian Rhythm Data as a Biomarker to Mitigate Health Risks

Completed Last updated 27 April 2020
What this trial tests

trial in Adolescent Behavior in 106 participants. Completed in 16 March 2020.

Timeline
6 May 2019
Primary endpoint
16 March 2020
16 March 2020

Quick facts

Lead sponsorDuke University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment106
Start date6 May 2019
Primary completion16 March 2020
Estimated completion16 March 2020
Sites1 location across United States

Conditions studied

Sponsor

Duke University

Who can join

Adults 11 to 17, any sex, with Adolescent Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goal of this study is to investigate associations between sleep/circadian disturbances and psychiatric health among adolescents recruited from primary and specialty health clinics.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Feasibility and Acceptability of Wearable Sleep Electroencephalogram Device Use in Adolescents: Observational Study.
    Lunsford-Avery JR, Keller C, Kollins SH, Krystal AD, et al · · 2020 · cited 15× · PMID 33001035 · DOI 10.2196/20590

Verify or expand the search:

Other recruiting trials for Adolescent Behavior

Currently open trials in the same condition.

Other Duke University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03843762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing